{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["astrocytes", "blood-spinal cord barrier", "microglia", "natural products", "neuroinflammation", "spinal cord injury"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34764668", "DateRevised": {"Year": "2021", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "02"}], "Language": ["eng"], "ELocationID": ["10.2147/JIR.S329864"], "Journal": {"ISSN": "1178-7031", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2021"}}, "Title": "Journal of inflammation research", "ISOAbbreviation": "J Inflamm Res"}, "ArticleTitle": "Neuroinflammation and Modulation Role of Natural Products After Spinal Cord Injury.", "Pagination": {"StartPage": "5713", "EndPage": "5737", "MedlinePgn": "5713-5737"}, "Abstract": {"AbstractText": ["Spinal cord injury (SCI) is a severe traumatic injury of the central nervous system, characterized by neurological dysfunction and locomotor disability. Although the underlying pathological mechanism of SCI is complex and remains unclear, the important role of neuroinflammation has been gradually unveiled in recent years. The inflammation process after SCI involves disruption of the blood-spinal cord barrier (BSCB), activation of gliocytes, infiltration of peripheral macrophages, and feedback loops between different cells. Thus, our first aim is to illustrate pathogenesis, related cells and factors of neuroinflammation after SCI in this review. Due to the good bioactivity of natural products derived from plants and medicinal herbs, these widely exist as food, health-care products and drugs in our lives. In the inflammation after SCI, multiple natural products exert satisfactory effects. Therefore, the second aim of this review is to sum up the effects and mechanisms of 25 natural compounds and 7 extracts derived from plants or medicinal herbs on neuroinflammation after SCI. Clarification of the SCI inflammation mechanism and a summary of the related natural products is helpful for in-depth research and drug development."], "CopyrightInformation": "\u00a9 2021 Wu et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi, The People's Republic of China."}], "LastName": "Wu", "ForeName": "Xue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi, The People's Republic of China."}], "LastName": "Yan", "ForeName": "Yaping", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi, The People's Republic of China."}], "LastName": "Zhang", "ForeName": "Qian", "Initials": "Q"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "J Inflamm Res", "NlmUniqueID": "101512684", "ISSNLinking": "1178-7031"}, "CoiStatement": "All authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Quadri SA, Farooqui M, Ikram A, et al. Recent update on basic mechanisms of spinal cord injury. Neurosurg Rev. 2020;43:425\u2013441. doi:10.1007/s10143-018-1008-3", "ArticleIdList": ["10.1007/s10143-018-1008-3", "29998371"]}, {"Citation": "Sun X, Jones ZB, Chen XM, et al. Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation. 2016;13:260. doi:10.1186/s12974-016-0736-y", "ArticleIdList": ["10.1186/s12974-016-0736-y", "PMC5053065", "27716334"]}, {"Citation": "Yong HYF, Rawji KS, Ghorbani S, et al. The benefits of neuroinflammation for the repair of the injured central nervous system. Cell Mol Immunol. 2019;16:540\u2013546. doi:10.1038/s41423-019-0223-3", "ArticleIdList": ["10.1038/s41423-019-0223-3", "PMC6804643", "30874626"]}, {"Citation": "Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209:378\u2013388. doi:10.1016/j.expneurol.2007.06.009", "ArticleIdList": ["10.1016/j.expneurol.2007.06.009", "PMC2692462", "17662717"]}, {"Citation": "Jin X, Liu MY, Zhang DF, et al. Natural products as a potential modulator of microglial polarization in neurodegenerative diseases. Pharmacol Res. 2019;145:104253. doi:10.1016/j.phrs.2019.104253", "ArticleIdList": ["10.1016/j.phrs.2019.104253", "31059788"]}, {"Citation": "Feng ST, Wang ZZ, Yuan YH, et al. Mangiferin: a multipotent natural product preventing neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s disease models. Pharmacol Res. 2019;146:104336. doi:10.1016/j.phrs.2019.104336", "ArticleIdList": ["10.1016/j.phrs.2019.104336", "31271846"]}, {"Citation": "Uchida Y, Yagi Y, Takao M, et al. Comparison of absolute protein abundances of transporters and receptors among blood-brain barriers at different cerebral regions and the blood-spinal cord barrier in humans and rats. Mol Pharm. 2020;17:2006\u20132020. doi:10.1021/acs.molpharmaceut.0c00178", "ArticleIdList": ["10.1021/acs.molpharmaceut.0c00178", "32310660"]}, {"Citation": "Jin LY, Li J, Wang KF, et al. Blood-spinal cord barrier in spinal cord injury: a review. J Neurotrauma. 2021;38:1203\u20131224. doi:10.1089/neu.2020.7413", "ArticleIdList": ["10.1089/neu.2020.7413", "33292072"]}, {"Citation": "Maikos JT, Shreiber DI. Immediate damage to the blood-spinal cord barrier due to mechanical trauma. J Neurotrauma. 2007;24:492\u2013507. doi:10.1089/neu.2006.0149", "ArticleIdList": ["10.1089/neu.2006.0149", "17402855"]}, {"Citation": "Figley SA, Khosravi R, Legasto JM, et al. Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. J Neurotrauma. 2014;31:541\u2013552. doi:10.1089/neu.2013.3034", "ArticleIdList": ["10.1089/neu.2013.3034", "PMC3949504", "24237182"]}, {"Citation": "Yang Y, Estrada EY, Thompson JF, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27:697\u2013709. doi:10.1038/sj.jcbfm.9600375", "ArticleIdList": ["10.1038/sj.jcbfm.9600375", "16850029"]}, {"Citation": "Hsu J-YC, McKeon R, Goussev S, et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci. 2006;26:9841\u20139850. doi:10.1523/JNEUROSCI.1993-06.2006", "ArticleIdList": ["10.1523/JNEUROSCI.1993-06.2006", "PMC2659718", "17005848"]}, {"Citation": "Lee JY, Choi HY, Ahn H-J, et al. Matrix metalloproteinase-3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury. Am J Pathol. 2014;184:2985\u20133000. doi:10.1016/j.ajpath.2014.07.016", "ArticleIdList": ["10.1016/j.ajpath.2014.07.016", "25325922"]}, {"Citation": "Yu F, Kamada H, Niizuma K, et al. Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma. 2008;25:184\u2013195. doi:10.1089/neu.2007.0438", "ArticleIdList": ["10.1089/neu.2007.0438", "PMC2365489", "18352832"]}, {"Citation": "Wells JEA, Rice TK, Nuttall RK, et al. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci. 2003;23:10107\u201310115. doi:10.1523/JNEUROSCI.23-31-10107.2003", "ArticleIdList": ["10.1523/JNEUROSCI.23-31-10107.2003", "PMC6740867", "14602826"]}, {"Citation": "Panahian N, Maines MD. Site of injury-directed induction of heme oxygenase-1 and \u22122 in experimental spinal cord injury: differential functions in neuronal defense mechanisms? J Neurochem. 2001;76:539\u2013554. doi:10.1046/j.1471-4159.2001.00023.x", "ArticleIdList": ["10.1046/j.1471-4159.2001.00023.x", "11208917"]}, {"Citation": "Lin Y, Vreman HJ, Wong RJ, et al. Heme oxygenase-1 stabilizes the blood-spinal cord barrier and limits oxidative stress and white matter damage in the acutely injured murine spinal cord. J Cereb Blood Flow Metab. 2007;27:1010\u20131021. doi:10.1038/sj.jcbfm.9600412", "ArticleIdList": ["10.1038/sj.jcbfm.9600412", "17047682"]}, {"Citation": "Liu Y, Tachibana T, Dai Y, et al. Heme oxygenase-1 expression after spinal cord injury: the induction in activated neutrophils. J Neurotrauma. 2002;19:479\u2013490. doi:10.1089/08977150252932424", "ArticleIdList": ["10.1089/08977150252932424", "11990353"]}, {"Citation": "Lee T-S, Chau L-Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8:240\u2013246. doi:10.1038/nm0302-240", "ArticleIdList": ["10.1038/nm0302-240", "11875494"]}, {"Citation": "Herrera JJ, Sundberg LM, Zentilin L, et al. Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury. J Neurotrauma. 2010;27:2067\u20132076. doi:10.1089/neu.2010.1403", "ArticleIdList": ["10.1089/neu.2010.1403", "PMC2978057", "20799882"]}, {"Citation": "Nourhaghighi N, Teichert-Kuliszewska K, Davis J, et al. Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab Invest. 2003;83:1211\u20131222. doi:10.1097/01.lab.0000082383.40635.fe", "ArticleIdList": ["10.1097/01.lab.0000082383.40635.fe", "12920250"]}, {"Citation": "Han S, Arnold SA, Sithu SD, et al. Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is protective after spinal cord injury. Brain. 2010;133:1026\u20131042. doi:10.1093/brain/awq034", "ArticleIdList": ["10.1093/brain/awq034", "PMC2850582", "20375135"]}, {"Citation": "Cabrera-Aldana EE, Ruelas F, Aranda C, et al. Methylprednisolone administration following spinal cord injury reduces aquaporin 4 expression and exacerbates edema. Mediators Inflamm. 2017;2017:4792932. doi:10.1155/2017/4792932", "ArticleIdList": ["10.1155/2017/4792932", "PMC5442433", "28572712"]}, {"Citation": "Kimura A, Hsu M, Seldin M, et al. Protective role of aquaporin-4 water channels after contusion spinal cord injury. Ann Neurol. 2010;67:794\u2013801. doi:10.1002/ana.22023", "ArticleIdList": ["10.1002/ana.22023", "20517941"]}, {"Citation": "Pan Y-L, Guo Y, Ma Y, et al. Aquaporin-4 expression dynamically varies after acute spinal cord injury-induced disruption of blood spinal cord barrier in rats. Neuropathology. 2019;39:181\u2013186. doi:10.1111/neup.12539", "ArticleIdList": ["10.1111/neup.12539", "30919512"]}, {"Citation": "Kitchen P, Salman MM, Halsey AM, et al. Targeting aquaporin-4 subcellular localization to treat central nervous system edema. Cell. 2020;181:784\u2013799. doi:10.1016/j.cell.2020.03.037", "ArticleIdList": ["10.1016/j.cell.2020.03.037", "PMC7242911", "32413299"]}, {"Citation": "Zeng C-W, Kamei Y, Shigenobu S, et al. Injury-induced Cavl-expressing cells at lesion rostral side play major roles in spinal cord regeneration. Open Biol. 2021;11:200304. doi:10.1098/rsob.200304", "ArticleIdList": ["10.1098/rsob.200304", "PMC8061693", "33622104"]}, {"Citation": "Shin T. Increases in the phosphorylated form of caveolin-1 in the spinal cord of rats with clip compression injury. Brain Res. 2007;1141:228\u2013234. doi:10.1016/j.brainres.2007.01.009", "ArticleIdList": ["10.1016/j.brainres.2007.01.009", "17275798"]}, {"Citation": "Song L, Ge S, Pachter JS. Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood. 2007;109:1515\u20131523. doi:10.1182/blood-2006-07-034009", "ArticleIdList": ["10.1182/blood-2006-07-034009", "PMC1794065", "17023578"]}, {"Citation": "Kigerl KA, Vaccari J, Dietrich WD, et al. Pattern recognition receptors and central nervous system repair. Exp Neurol. 2014;258:5\u201316. doi:10.1016/j.expneurol.2014.01.001", "ArticleIdList": ["10.1016/j.expneurol.2014.01.001", "PMC4974939", "25017883"]}, {"Citation": "Amarante-Mendes GP, Adjemian S, Branco LM, et al. Pattern recognition receptors and the host cell death molecular machinery. Front Immunol. 2018;9:2379. doi:10.3389/fimmu.2018.02379", "ArticleIdList": ["10.3389/fimmu.2018.02379", "PMC6232773", "30459758"]}, {"Citation": "David BT, Ratnayake A, Amarante MA, et al. A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury. Neurobiol Dis. 2013;54:194\u2013205. doi:10.1016/j.nbd.2012.12.012", "ArticleIdList": ["10.1016/j.nbd.2012.12.012", "23313320"]}, {"Citation": "Kigerl KA, Lai W, Rivest S, et al. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem. 2007;102:37\u201350. doi:10.1111/j.1471-4159.2007.04524.x", "ArticleIdList": ["10.1111/j.1471-4159.2007.04524.x", "17403033"]}, {"Citation": "Vaccari J, Minkiewicz J, Wang X, et al. Astrogliosis involves activation of retinoic acid-inducible gene-like signaling in the innate immune response after spinal cord injury. Glia. 2012;60:414\u2013421. doi:10.1002/glia.22275", "ArticleIdList": ["10.1002/glia.22275", "PMC3265608", "22161971"]}, {"Citation": "Orr MB, Gensel JC. Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics. 2018;15:541\u2013553. doi:10.1007/s13311-018-0631-6", "ArticleIdList": ["10.1007/s13311-018-0631-6", "PMC6095779", "29717413"]}, {"Citation": "Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456\u20131458. doi:10.1126/science.1202529", "ArticleIdList": ["10.1126/science.1202529", "21778362"]}, {"Citation": "Ueno M, Fujita Y, Tanaka T, et al. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci. 2013;16:543\u2013551. doi:10.1038/nn.3358", "ArticleIdList": ["10.1038/nn.3358", "23525041"]}, {"Citation": "Hagemeyer N, Hanft K-M, Akriditou M-A, et al. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol. 2017;134:441\u2013458. doi:10.1007/s00401-017-1747-1", "ArticleIdList": ["10.1007/s00401-017-1747-1", "PMC5951721", "28685323"]}, {"Citation": "Hanke ML, Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci. 2011;121:367\u2013387. doi:10.1042/CS20110164", "ArticleIdList": ["10.1042/CS20110164", "PMC4231819", "21745188"]}, {"Citation": "Gaudet AD, Fonken LK. Glial cells shape pathology and repair after spinal cord injury. Neurotherapeutics. 2018;15:554\u2013577. doi:10.1007/s13311-018-0630-7", "ArticleIdList": ["10.1007/s13311-018-0630-7", "PMC6095774", "29728852"]}, {"Citation": "Beck KD, Nguyen HX, Galvan MD, et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 2010;133:433\u2013447. doi:10.1093/brain/awp322", "ArticleIdList": ["10.1093/brain/awp322", "PMC2858013", "20085927"]}, {"Citation": "Kigerl KA, Gensel JC, Ankeny DP, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435\u201313444. doi:10.1523/JNEUROSCI.3257-09.2009", "ArticleIdList": ["10.1523/JNEUROSCI.3257-09.2009", "PMC2788152", "19864556"]}, {"Citation": "Hu X, Leak RK, Shi Y, et al. Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol. 2015;11:56\u201364. doi:10.1038/nrneurol.2014.207", "ArticleIdList": ["10.1038/nrneurol.2014.207", "PMC4395497", "25385337"]}, {"Citation": "Gensel JC, Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 2015;1619:1\u201311. doi:10.1016/j.brainres.2014.12.045", "ArticleIdList": ["10.1016/j.brainres.2014.12.045", "25578260"]}, {"Citation": "Halassa MM, Fellin T, Takano H, et al. Synaptic islands defined by the territory of a single astrocyte. J Neurosci. 2007;27:6473\u20136477. doi:10.1523/JNEUROSCI.1419-07.2007", "ArticleIdList": ["10.1523/JNEUROSCI.1419-07.2007", "PMC6672436", "17567808"]}, {"Citation": "G\u00f3mez-Gonzalo M, Martin-Fernandez M, Mart\u00ednez-Murillo R, et al. Neuron-astrocyte signaling is preserved in the aging brain. Glia. 2017;65:569\u2013580. doi:10.1002/glia.23112", "ArticleIdList": ["10.1002/glia.23112", "PMC5314210", "28130845"]}, {"Citation": "Stogsdill JA, Ramirez J, Liu D, et al. Astrocytic neuroligins control astrocyte morphogenesis and synaptogenesis. Nature. 2017;551:192\u2013197. doi:10.1038/nature24638", "ArticleIdList": ["10.1038/nature24638", "PMC5796651", "29120426"]}, {"Citation": "Liebner S, Dijkhuizen RM, Reiss Y, et al. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135:311\u2013336. doi:10.1007/s00401-018-1815-1", "ArticleIdList": ["10.1007/s00401-018-1815-1", "PMC6781630", "29411111"]}, {"Citation": "Attwell D, Buchan AM, Charpak S, et al. Glial and neuronal control of brain blood flow. Nature. 2010;468:232\u2013243. doi:10.1038/nature09613", "ArticleIdList": ["10.1038/nature09613", "PMC3206737", "21068832"]}, {"Citation": "B\u00e9langer M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14:724\u2013738. doi:10.1016/j.cmet.2011.08.016", "ArticleIdList": ["10.1016/j.cmet.2011.08.016", "22152301"]}, {"Citation": "Jensen CJ, Massie A, Keyser JD. Immune players in the CNS: the astrocyte. J Neuroimmune Pharmacol. 2013;8:824\u2013839. doi:10.1007/s11481-013-9480-6", "ArticleIdList": ["10.1007/s11481-013-9480-6", "23821340"]}, {"Citation": "Li L, Acioglu C, Heary RF, et al. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun. 2021;91:740\u2013755. doi:10.1016/j.bbi.2020.10.007", "ArticleIdList": ["10.1016/j.bbi.2020.10.007", "PMC7543714", "33039660"]}, {"Citation": "Rivieccio MA, Suh H-S, Zhao Y, et al. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol. 2006;177:4735\u20134741. doi:10.4049/jimmunol.177.7.4735", "ArticleIdList": ["10.4049/jimmunol.177.7.4735", "16982913"]}, {"Citation": "Karimi-Abdolrezaee S, Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol Neurobiol. 2012;46:251\u2013264. doi:10.1007/s12035-012-8287-4", "ArticleIdList": ["10.1007/s12035-012-8287-4", "22684804"]}, {"Citation": "Almutairi MMA, Gong C, Xu YG, et al. Factors controlling permeability of the blood-brain barrier. Cell Mol Life Sci. 2016;73:57\u201377. doi:10.1007/s00018-015-2050-8", "ArticleIdList": ["10.1007/s00018-015-2050-8", "26403789"]}, {"Citation": "Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012;33:579\u2013589. doi:10.1016/j.it.2012.07.004", "ArticleIdList": ["10.1016/j.it.2012.07.004", "22926201"]}, {"Citation": "Gorina R, Font-Nieves M, M\u00e1rquez-Kisinousky L, et al. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NF\u03baB signaling, MAPK, and Jak1/Stat1 pathways. Glia. 2011;59:242\u2013255. doi:10.1002/glia.21094", "ArticleIdList": ["10.1002/glia.21094", "21125645"]}, {"Citation": "McKimmie CS, Graham GJ. Astrocytes modulate the chemokine network in a pathogen-specific manner. Biochem Biophys Res Commun. 2010;394:1006\u20131011. doi:10.1016/j.bbrc.2010.03.111", "ArticleIdList": ["10.1016/j.bbrc.2010.03.111", "20331977"]}, {"Citation": "Pedrazzi M, Patrone M, Passalacqua M, et al. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J Immunol. 2007;179:8525\u20138532. doi:10.4049/jimmunol.179.12.8525", "ArticleIdList": ["10.4049/jimmunol.179.12.8525", "18056400"]}, {"Citation": "Moreno M, Guo F, Ko EM, et al. Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE. J Neurol Sci. 2013;333:55\u201359. doi:10.1016/j.jns.2012.12.014", "ArticleIdList": ["10.1016/j.jns.2012.12.014", "PMC3624040", "23294494"]}, {"Citation": "Dong Y, Benveniste EN. Immune function of astrocytes. Glia. 2001;36:180\u2013190. doi:10.1002/glia.1107", "ArticleIdList": ["10.1002/glia.1107", "11596126"]}, {"Citation": "Rostami J, Fotaki G, Sirois J, et al. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson\u2019s disease brain. J Neuroinflammation. 2020;17:119. doi:10.1186/s12974-020-01776-7", "ArticleIdList": ["10.1186/s12974-020-01776-7", "PMC7164247", "32299492"]}, {"Citation": "Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32:6391\u20136410. doi:10.1523/JNEUROSCI.6221-11.2012", "ArticleIdList": ["10.1523/JNEUROSCI.6221-11.2012", "PMC3480225", "22553043"]}, {"Citation": "Tarassishin L, Suh H-S, Lee SC. LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14. Glia. 2014;62:999\u20131013. doi:10.1002/glia.22657", "ArticleIdList": ["10.1002/glia.22657", "PMC4015139", "24659539"]}, {"Citation": "Maupu C, Enderlin J, Igert A, et al. Diisopropylfluorophosphate-induced status epilepticus drives complex glial cell phenotypes in adult male mice. Neurobiol Dis. 2021;152:105276. doi:10.1016/j.nbd.2021.105276", "ArticleIdList": ["10.1016/j.nbd.2021.105276", "33529768"]}, {"Citation": "Giovannoni F, Quintana FJ. The role of astrocytes in CNS inflammation. Trends Immunol. 2020;41:805\u2013819. doi:10.1016/j.it.2020.07.007", "ArticleIdList": ["10.1016/j.it.2020.07.007", "PMC8284746", "32800705"]}, {"Citation": "Yan Y, Ding X, Li K, et al. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol Ther. 2012;20:1338\u20131348. doi:10.1038/mt.2012.12", "ArticleIdList": ["10.1038/mt.2012.12", "PMC3392982", "22434134"]}, {"Citation": "Su Y, Chen Z, Du H, et al. Silencing miR-21 induces polarization of astrocytes to the A2 phenotype and improves the formation of synapses by targeting glypican 6 via the signal transducer and activator of transcription-3 pathway after acute ischemic spinal cord injury. FASEB J. 2019;33:10859\u201310871. doi:10.1096/fj.201900743R", "ArticleIdList": ["10.1096/fj.201900743R", "31266356"]}, {"Citation": "Zhao N, Xu X, Jiang Y, et al. Lipocalin-2 may produce damaging effect after cerebral ischemia by inducing astrocytes classical activation. J Neuroinflammation. 2019;16:168. doi:10.1186/s12974-019-1556-7", "ArticleIdList": ["10.1186/s12974-019-1556-7", "PMC6699078", "31426811"]}, {"Citation": "Karababa A, Groos-Sahr K, Albrecht U, et al. Ammonia attenuates LPS-induced upregulation of pro-inflammatory cytokine mRNA in co-cultured astrocytes and microglia. Neurochem Res. 2017;42:737\u2013749. doi:10.1007/s11064-016-2060-4", "ArticleIdList": ["10.1007/s11064-016-2060-4", "27655254"]}, {"Citation": "Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u2013487. doi:10.1038/nature21029", "ArticleIdList": ["10.1038/nature21029", "PMC5404890", "28099414"]}, {"Citation": "Lepore AC, O\u2019Donnell J, Kim AS, et al. Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury. Glia. 2011;59:1996\u20132005. doi:10.1002/glia.21241", "ArticleIdList": ["10.1002/glia.21241", "PMC3269541", "21882244"]}, {"Citation": "Bezzi P, Domercq M, Brambilla L, et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci. 2001;4:702\u2013710. doi:10.1038/89490", "ArticleIdList": ["10.1038/89490", "11426226"]}, {"Citation": "Norden DM, Fenn AM, Dugan A, et al. TGF\u03b2 produced by IL-10 redirected astrocytes attenuates microglial activation. Glia. 2014;62:881\u2013895. doi:10.1002/glia.22647", "ArticleIdList": ["10.1002/glia.22647", "PMC4061706", "24616125"]}, {"Citation": "Steelman AJ, Li J. Astrocyte galectin-9 potentiates microglial TNF secretion. J Neuroinflammation. 2014;11:144. doi:10.1186/s12974-014-0144-0", "ArticleIdList": ["10.1186/s12974-014-0144-0", "PMC4158089", "25158758"]}, {"Citation": "Peterson SL, Nguyen HX, Mendez OA, et al. Complement protein C3 suppresses axon growth and promotes neuron loss. Sci Rep. 2017;7:12904. doi:10.1038/s41598-017-11410-x", "ArticleIdList": ["10.1038/s41598-017-11410-x", "PMC5635131", "29018286"]}, {"Citation": "Lian H, Litvinchuk A, Chiang -AC-A, et al. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease. J Neurosci. 2016;36:577\u2013589. doi:10.1523/JNEUROSCI.2117-15.2016", "ArticleIdList": ["10.1523/JNEUROSCI.2117-15.2016", "PMC4710776", "26758846"]}, {"Citation": "Hung -C-C, Lin C-H, Chang H, et al. Astrocytic GAP43 induced by the TLR4/NF-\u03baB/STAT3 axis attenuates astrogliosis-mediated microglial activation and neurotoxicity. J Neurosci. 2016;36:2027\u20132043. doi:10.1523/JNEUROSCI.3457-15.2016", "ArticleIdList": ["10.1523/JNEUROSCI.3457-15.2016", "PMC6602016", "26865625"]}, {"Citation": "Acevedo G, Padala NK, Ni L, et al. Astrocytes inhibit microglial surface expression of dendritic cell-related co-stimulatory molecules through a contact-mediated process. J Neurochem. 2013;125:575\u2013587. doi:10.1111/jnc.12221", "ArticleIdList": ["10.1111/jnc.12221", "PMC3637427", "23439211"]}, {"Citation": "Zhou R, Gao J, Xiang C, et al. Salvianolic acid A attenuated myocardial infarction-induced apoptosis and inflammation by activating Trx. Naunyn Schmiedebergs Arch Pharmacol. 2020;393:991\u20131002. doi:10.1007/s00210-019-01766-4", "ArticleIdList": ["10.1007/s00210-019-01766-4", "31811327"]}, {"Citation": "Liu C-D, Liu -N-N, Zhang S, et al. Salvianolic acid A prevented cerebrovascular endothelial injury caused by acute ischemic stroke through inhibiting the Src signaling pathway. Acta Pharmacol Sin. 2021;42:370\u2013381. doi:10.1038/s41401-020-00568-2", "ArticleIdList": ["10.1038/s41401-020-00568-2", "PMC8027612", "33303991"]}, {"Citation": "Zhu J, Wang R, Xu T, et al. Salvianolic acid A attenuates endoplasmic reticulum stress and protects against cholestasis-induced liver fibrosis via the SIRT1/HSF1 pathway. Front Pharmacol. 2018;9:1277. doi:10.3389/fphar.2018.01277", "ArticleIdList": ["10.3389/fphar.2018.01277", "PMC6230567", "30455644"]}, {"Citation": "Zhou A-M, Xiang Y-J, Liu E-Q, et al. Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus. BMC Cardiovasc Disord. 2020;20:15. doi:10.1186/s12872-019-01316-z", "ArticleIdList": ["10.1186/s12872-019-01316-z", "PMC6956554", "31931718"]}, {"Citation": "Yu D-S, Wang Y-S, Bi Y-L, et al. Salvianolic acid A ameliorates the integrity of blood-spinal cord barrier via miR-101/Cul3/Nrf2/HO-1 signaling pathway. Brain Res. 2017;1657:279\u2013287. doi:10.1016/j.brainres.2016.12.007", "ArticleIdList": ["10.1016/j.brainres.2016.12.007", "28011395"]}, {"Citation": "Wu Y, Xu S, Tian XY. The effect of salvianolic acid on vascular protection and possible mechanisms. Oxid Med Cell Longev. 2020;2020:5472096. doi:10.1155/2020/5472096", "ArticleIdList": ["10.1155/2020/5472096", "PMC7533016", "33062143"]}, {"Citation": "Li Z-M, Xu S-W, Liu P-Q. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 2018;39:802\u2013824. doi:10.1038/aps.2017.193", "ArticleIdList": ["10.1038/aps.2017.193", "PMC5943903", "29698387"]}, {"Citation": "Fan Z-K, Lv G, Wang Y-F, et al. The protective effect of salvianolic acid B on blood-spinal cord barrier after compression spinal cord injury in rats. J Mol Neurosci. 2013;51:986\u2013993. doi:10.1007/s12031-013-0083-8", "ArticleIdList": ["10.1007/s12031-013-0083-8", "23943397"]}, {"Citation": "Fu J, Fan H-B, Guo Z, et al. Salvianolic acid B attenuates spinal cord ischemia-reperfusion-induced neuronal injury and oxidative stress by activating the extracellular signal-regulated kinase pathway in rats. J Surg Res. 2014;188:222\u2013230. doi:10.1016/j.jss.2013.11.1118", "ArticleIdList": ["10.1016/j.jss.2013.11.1118", "24387840"]}, {"Citation": "Krzysztoforska K, Mirowska-Guzel D, Widy-Tyszkiewicz E. Pharmacological effects of protocatechuic acid and its therapeutic potential in neurodegenerative diseases: review on the basis of in vitro and in vivo studies in rodents and humans. Nutr Neurosci. 2019;22:72\u201382. doi:10.1080/1028415X.2017.1354543", "ArticleIdList": ["10.1080/1028415X.2017.1354543", "28745142"]}, {"Citation": "Park CS, Lee JY, Choi HY, et al. Protocatechuic acid improves functional recovery after spinal cord injury by attenuating blood-spinal cord barrier disruption and hemorrhage in rats. Neurochem Int. 2019;124:181\u2013192. doi:10.1016/j.neuint.2019.01.013", "ArticleIdList": ["10.1016/j.neuint.2019.01.013", "30664898"]}, {"Citation": "Hu J-Z, Huang J-H, Xiao Z-M, et al. Tetramethylpyrazine accelerates the function recovery of traumatic spinal cord in rat model by attenuating inflammation. J Neurol Sci. 2013;324:94\u201399. doi:10.1016/j.jns.2012.10.009", "ArticleIdList": ["10.1016/j.jns.2012.10.009", "23140983"]}, {"Citation": "Wang C, Wang P, Zeng W, et al. Tetramethylpyrazine improves the recovery of spinal cord injury via Akt/Nrf2/HO-1 pathway. Bioorg Med Chem Lett. 2016;26:1287\u20131291. doi:10.1016/j.bmcl.2016.01.015", "ArticleIdList": ["10.1016/j.bmcl.2016.01.015", "26786697"]}, {"Citation": "Fan L, Wang K, Shi Z, et al. Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury. J Vasc Surg. 2011;54:192\u2013200. doi:10.1016/j.jvs.2010.12.030", "ArticleIdList": ["10.1016/j.jvs.2010.12.030", "21458204"]}, {"Citation": "Shin J-W, Moon J-Y, Seong J-W, et al. Effects of tetramethylpyrazine on microglia activation in spinal cord compression injury of mice. Am J Chin Med. 2013;41:1361\u20131376. doi:10.1142/S0192415X13500912", "ArticleIdList": ["10.1142/S0192415X13500912", "24228606"]}, {"Citation": "Zhang L, Lu X, Gong L, et al. Tetramethylpyrazine protects blood-spinal cord barrier integrity by modulating microglia polarization through activation of STAT3/SOCS3 and inhibition of NF-\u043aB signaling pathways in experimental autoimmune encephalomyelitis mice. Cell Mol Neurobiol. 2021;41:717\u2013731. doi:10.1007/s10571-020-00878-3", "ArticleIdList": ["10.1007/s10571-020-00878-3", "32424774"]}, {"Citation": "Du Q-H, Peng C, Zhang H. Polydatin: a review of pharmacology and pharmacokinetics. Pharm Biol. 2013;51:1347\u20131354. doi:10.3109/13880209.2013.792849", "ArticleIdList": ["10.3109/13880209.2013.792849", "23862567"]}, {"Citation": "Lv R, Du L, Liu X, et al. Polydatin alleviates traumatic spinal cord injury by reducing microglial inflammation via regulation of iNOS and NLRP3 inflammasome pathway. Int Immunopharmacol. 2019;70:28\u201336. doi:10.1016/j.intimp.2019.02.006", "ArticleIdList": ["10.1016/j.intimp.2019.02.006", "30785088"]}, {"Citation": "Zhou Y-X, Gong X-H, Zhang H, et al. A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects. Biomed Pharmacother. 2020;130:110505. doi:10.1016/j.biopha.2020.110505", "ArticleIdList": ["10.1016/j.biopha.2020.110505", "32682112"]}, {"Citation": "Wang B, Dai W, Shi L, et al. Neuroprotection by paeoniflorin against nuclear factor kappa B-induced neuroinflammation on spinal cord injury. Biomed Res Int. 2018;2018:9865403. doi:10.1155/2018/9865403", "ArticleIdList": ["10.1155/2018/9865403", "PMC6304651", "30627586"]}, {"Citation": "Liu P, Cheng J, Ma S, et al. Paeoniflorin attenuates chronic constriction injury\u2011induced neuropathic pain by suppressing spinal NLRP3 inflammasome activation. Inflammopharmacology. 2020;28:1495\u20131508. doi:10.1007/s10787-020-00737-z", "ArticleIdList": ["10.1007/s10787-020-00737-z", "32596762"]}, {"Citation": "Meeran MFN, Goyal SN, Suchal K, et al. Pharmacological properties, molecular mechanisms, and pharmaceutical development of asiatic acid: a pentacyclic triterpenoid of therapeutic promise. Front Pharmacol. 2018;9:892.", "ArticleIdList": ["PMC6131672", "30233358"]}, {"Citation": "Gurcan O, Gurcay AG, Kazanci A, et al. Effect of asiatic acid on the treatment of spinal cord injury: an experimental study in rats. Turk Neurosurg. 2017;27:259\u2013264. doi:10.5137/1019-5149.JTN.15747-15.2", "ArticleIdList": ["10.5137/1019-5149.JTN.15747-15.2", "27593768"]}, {"Citation": "Jiang W, Li M, He F, et al. Neuroprotective effect of asiatic acid against spinal cord injury in rats. Life Sci. 2016;157:45\u201351. doi:10.1016/j.lfs.2016.05.004", "ArticleIdList": ["10.1016/j.lfs.2016.05.004", "27153777"]}, {"Citation": "Rocha J, Eduardo-Figueira M, Barateiro A, et al. Anti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation. Basic Clin Pharmacol Toxicol. 2015;116:398\u2013413. doi:10.1111/bcpt.12335", "ArticleIdList": ["10.1111/bcpt.12335", "25287116"]}, {"Citation": "Shang A-J, Yang Y, Wang H-Y, et al. Spinal cord injury effectively ameliorated by neuroprotective effects of rosmarinic acid. Nutr Neurosci. 2017;20:172\u2013179. doi:10.1080/1028415X.2015.1103460", "ArticleIdList": ["10.1080/1028415X.2015.1103460", "26796989"]}, {"Citation": "Ma Z, Lu Y, Yang F, et al. Rosmarinic acid exerts a neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-\u03baB pathways. Toxicol Appl Pharmacol. 2020;397:115014. doi:10.1016/j.taap.2020.115014", "ArticleIdList": ["10.1016/j.taap.2020.115014", "32320792"]}, {"Citation": "Zhou Y-X, Zhang H, Peng C. Puerarin: a review of pharmacological effects. Phytother Res. 2014;28:961\u2013975. doi:10.1002/ptr.5083", "ArticleIdList": ["10.1002/ptr.5083", "24339367"]}, {"Citation": "Zhang D, Ma G, Hou M, et al. The neuroprotective effect of puerarin in acute spinal cord injury rats. Cell Physiol Biochem. 2016;39:1152\u20131164. doi:10.1159/000447822", "ArticleIdList": ["10.1159/000447822", "27576607"]}, {"Citation": "Liu M, Liao K, Yu C, et al. Puerarin alleviates neuropathic pain by inhibiting neuroinflammation in spinal cord. Mediators Inflamm. 2014;2014:485927. doi:10.1155/2014/485927", "ArticleIdList": ["10.1155/2014/485927", "PMC4096058", "25089076"]}, {"Citation": "Li N, Ou J, Bao N, et al. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition. Bioorg Chem. 2020;104:104208. doi:10.1016/j.bioorg.2020.104208", "ArticleIdList": ["10.1016/j.bioorg.2020.104208", "32919131"]}, {"Citation": "Zhang W, Cheng L, Hou Y, et al. Plumbagin protects against spinal cord injury-induced oxidative stress and inflammation in Wistar rats through Nrf-2 upregulation. Drug Res. 2015;65:495\u2013499. doi:10.1055/s-0034-1389950", "ArticleIdList": ["10.1055/s-0034-1389950", "25243650"]}, {"Citation": "Yang W, Yang Y, Yang J-Y, et al. Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptosis and the activation of the Nrf2 pathway. Int J Mol Med. 2016;37:1075\u20131082. doi:10.3892/ijmm.2016.2498", "ArticleIdList": ["10.3892/ijmm.2016.2498", "26936518"]}, {"Citation": "Wang S, Ren D. Allicin protects traumatic spinal cord injury through regulating the HSP70/Akt/iNOS pathway in mice. Mol Med Rep. 2016;14:3086\u20133092. doi:10.3892/mmr.2016.5651", "ArticleIdList": ["10.3892/mmr.2016.5651", "PMC5042739", "27573340"]}, {"Citation": "Lv R, Mao N, Wu J, et al. Neuroprotective effect of allicin in a rat model of acute spinal cord injury. Life Sci. 2015;143:114\u2013123. doi:10.1016/j.lfs.2015.11.001", "ArticleIdList": ["10.1016/j.lfs.2015.11.001", "26546416"]}, {"Citation": "Liu S-G, Ren P-Y, Wang G-Y, et al. Allicin protects spinal cord neurons from glutamate-induced oxidative stress through regulating the heat shock protein 70/inducible nitric oxide synthase pathway. Food Funct. 2015;6:321\u2013330. doi:10.1039/c4fo00761a", "ArticleIdList": ["10.1039/c4fo00761a", "25473931"]}, {"Citation": "Vincenzo AD, Tana C, Hadi HE, et al. Antioxidant, anti-Inflammatory, and metabolic properties of tocopherols and tocotrienols: clinical implications for vitamin E supplementation in diabetic kidney disease. Int J Mol Sci. 2019;20:5101. doi:10.3390/ijms20205101", "ArticleIdList": ["10.3390/ijms20205101", "PMC6834186", "31618817"]}, {"Citation": "Ghanem P, Zouein A, Mohamad M, et al. The vitamin E derivative gamma tocotrienol promotes anti-tumor effects in acute myeloid leukemia cell lines. Nutrients. 2019;11:2808. doi:10.3390/nu11112808", "ArticleIdList": ["10.3390/nu11112808", "PMC6893610", "31744219"]}, {"Citation": "Frank J, Chin XWD, Schrader C, et al. Do tocotrienols have potential as neuroprotective dietary factors? Ageing Res Rev. 2012;11:163\u2013180. doi:10.1016/j.arr.2011.06.006", "ArticleIdList": ["10.1016/j.arr.2011.06.006", "21763788"]}, {"Citation": "Xun C, Mamat M, Guo H, et al. Tocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-\u03b2. Exp Ther Med. 2017;14:431\u2013438. doi:10.3892/etm.2017.4505", "ArticleIdList": ["10.3892/etm.2017.4505", "PMC5488605", "28672950"]}, {"Citation": "Ho Y, Lin Y-S, Liu H-L, et al. Biological mechanisms by which antiproliferative actions of resveratrol are minimized. Nutrients. 2017;9:1046. doi:10.3390/nu9101046", "ArticleIdList": ["10.3390/nu9101046", "PMC5691663", "28934112"]}, {"Citation": "Xia N, Daiber A, F\u00f6rstermann U, et al. Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol. 2017;174:1633\u20131646. doi:10.1111/bph.13492", "ArticleIdList": ["10.1111/bph.13492", "PMC5446570", "27058985"]}, {"Citation": "Xu D, Li Y, Zhang B, et al. Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats. Int J Med Sci. 2016;13:942\u2013954. doi:10.7150/ijms.16810", "ArticleIdList": ["10.7150/ijms.16810", "PMC5165688", "27994500"]}, {"Citation": "Liu C, Shi Z, Fan L, et al. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res. 2011;1374:100\u2013109. doi:10.1016/j.brainres.2010.11.061", "ArticleIdList": ["10.1016/j.brainres.2010.11.061", "21111721"]}, {"Citation": "Fan R, Zhang Y, Botchway BOA, et al. Resveratrol can attenuate astrocyte activation to treat spinal cord injury by inhibiting inflammatory responses. Mol Neurobiol. 2021;19:1\u201315. doi:10.1007/s12035-021-02509-4", "ArticleIdList": ["10.1007/s12035-021-02509-4", "PMC8374881", "34410605"]}, {"Citation": "Zhao H, Chen S, Gao K, et al. Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway. Neuroscience. 2017;348:241\u2013254. doi:10.1016/j.neuroscience.2017.02.027", "ArticleIdList": ["10.1016/j.neuroscience.2017.02.027", "28238848"]}, {"Citation": "Xu L, Botchway BOA, Zhang S, et al. Inhibition of NF-\u03baB signaling pathway by resveratrol improves spinal cord injury. Front Neurosci. 2018;12. doi:10.3389/fnins.2018.00690", "ArticleIdList": ["10.3389/fnins.2018.00690", "PMC6180204", "30337851"]}, {"Citation": "Ge R, Zhu Y, Diao Y, et al. Anti-edema effect of epigallocatechin gallate on spinal cord injury in rats. Brain Res. 2013;1527:40\u201346. doi:10.1016/j.brainres.2013.06.009", "ArticleIdList": ["10.1016/j.brainres.2013.06.009", "23831998"]}, {"Citation": "Urdzikova LM, Ruzicka J, Karova K, et al. A green tea polyphenol epigallocatechin-3-gallate enhances neuroregeneration after spinal cord injury by altering levels of inflammatory cytokines. Neuropharmacology. 2017;126:213\u2013223. doi:10.1016/j.neuropharm.2017.09.006", "ArticleIdList": ["10.1016/j.neuropharm.2017.09.006", "28899730"]}, {"Citation": "Liu L, Zhang W, Wang L, et al. Curcumin prevents cerebral ischemia reperfusion injury via increase of mitochondrial biogenesis. Neurochem Res. 2014;39:1322\u20131331. doi:10.1007/s11064-014-1315-1", "ArticleIdList": ["10.1007/s11064-014-1315-1", "24777807"]}, {"Citation": "Samini F, Samarghandian S, Borji A, et al. Curcumin pretreatment attenuates brain lesion size and improves neurological function following traumatic brain injury in the rat. Pharmacol Biochem Behav. 2013;110:238\u2013244. doi:10.1016/j.pbb.2013.07.019", "ArticleIdList": ["10.1016/j.pbb.2013.07.019", "23932920"]}, {"Citation": "Yu D-S, Cao Y, Mei X-F, et al. Curcumin improves the integrity of blood-spinal cord barrier after compressive spinal cord injury in rats. J Neurol Sci. 2014;346:51\u201359. doi:10.1016/j.jns.2014.07.056", "ArticleIdList": ["10.1016/j.jns.2014.07.056", "25129208"]}, {"Citation": "Daverey A, Agrawal SK. Curcumin protects against white matter injury through NF-\u03baB and Nrf2 cross talk. J Neurotrauma. 2020;37:1255\u20131265. doi:10.1089/neu.2019.6749", "ArticleIdList": ["10.1089/neu.2019.6749", "31914858"]}, {"Citation": "Yuan J, Zou M, Xiang X, et al. Curcumin improves neural function after spinal cord injury by the joint inhibition of the intracellular and extracellular components of glial scar. J Surg Res. 2015;195:235\u2013245. doi:10.1016/j.jss.2014.12.055", "ArticleIdList": ["10.1016/j.jss.2014.12.055", "25661742"]}, {"Citation": "Gao F, Shen J, Zhao L, et al. Curcumin alleviates lipopolysaccharide (LPS)-activated neuroinflammation via modulation of miR-199b-5p/IkB kinase \u03b2 (IKKb)/nuclear factor kappa B (NF-\u03baB) pathway in microglia. Med Sci Monit. 2019;25:9801\u20139810. doi:10.12659/MSM.918237", "ArticleIdList": ["10.12659/MSM.918237", "PMC6937907", "31862869"]}, {"Citation": "Barboza JN, Filho C, Silva RO, et al. An overview on the anti-inflammatory potential and antioxidant profile of eugenol. Oxid Med Cell Longev. 2018;2018:3957262. doi:10.1155/2018/3957262", "ArticleIdList": ["10.1155/2018/3957262", "PMC6217746", "30425782"]}, {"Citation": "Ma L, Mu Y, Zhang Z, et al. Eugenol promotes functional recovery and alleviates inflammation, oxidative stress, and neural apoptosis in a rat model of spinal cord injury. Restor Neurol Neurosci. 2018;36:659\u2013668.", "ArticleIdList": ["30040768"]}, {"Citation": "Liu Y, Gao J, Peng M, et al. A review on central nervous system effects of gastrodin. Front Pharmacol. 2018;9:24. doi:10.3389/fphar.2018.00024", "ArticleIdList": ["10.3389/fphar.2018.00024", "PMC5801292", "29456504"]}, {"Citation": "Du F, Wang X, Shang B, et al. Gastrodin ameliorates spinal cord injury via antioxidant and anti-inflammatory effects. Acta Biochim Pol. 2016;63:589\u2013593. doi:10.18388/abp.2016_1272", "ArticleIdList": ["10.18388/abp.2016_1272", "27474401"]}, {"Citation": "Hu J-Z, Wang X-K, Cao Y, et al. Potentiation of spinal cord conduction and neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord injury induced functional outcome, blood-spinal cord barrier breakdown and edema formation. Int Rev Neurobiol. 2019;146:153\u2013188. doi:10.1016/bs.irn.2019.06.009", "ArticleIdList": ["10.1016/bs.irn.2019.06.009", "31349926"]}, {"Citation": "Zheng B, Zhou Y, Zhang H, et al. Dl-3-n-butylphthalide prevents the disruption of blood-spinal cord barrier via inhibiting endoplasmic reticulum stress following spinal cord injury. Int J Biol Sci. 2017;13:1520\u20131531. doi:10.7150/ijbs.21107", "ArticleIdList": ["10.7150/ijbs.21107", "PMC5723918", "29230100"]}, {"Citation": "Ye Z-Y, Xing H-Y, Wang B, et al. DL-3-n-butylphthalide protects the blood-brain barrier against ischemia/hypoxia injury via upregulation of tight junction proteins. Chin Med J. 2019;132:1344\u20131353. doi:10.1097/CM9.0000000000000232", "ArticleIdList": ["10.1097/CM9.0000000000000232", "PMC6629356", "30939485"]}, {"Citation": "He Z, Zhou Y, Lin L, et al. Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4/NF-\u03baB signalling. J Cell Mol Med. 2017;21:3010\u20133022. doi:10.1111/jcmm.13212", "ArticleIdList": ["10.1111/jcmm.13212", "PMC5661102", "28842949"]}, {"Citation": "Sowndhararajan K, Deepa P, Kim M, et al. Neuroprotective and cognitive enhancement potentials of baicalin: a review. Brain Sci. 2018;8:104. doi:10.3390/brainsci8060104", "ArticleIdList": ["10.3390/brainsci8060104", "PMC6025220", "29891783"]}, {"Citation": "Cao Y, Lia G, Wang Y-F, et al. Neuroprotective effect of baicalin on compression spinal cord injury in rats. Brain Res. 2010;1357:115\u2013123. doi:10.1016/j.brainres.2010.07.108", "ArticleIdList": ["10.1016/j.brainres.2010.07.108", "20708606"]}, {"Citation": "Tu X-K, Yang W-Z, Liang R-S, et al. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem Res. 2011;36:2022\u20132028. doi:10.1007/s11064-011-0526-y", "ArticleIdList": ["10.1007/s11064-011-0526-y", "21678122"]}, {"Citation": "Zhu H, Wang Z, Xing Y, et al. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J Ethnopharmacol. 2012;141:714\u2013720. doi:10.1016/j.jep.2011.08.063", "ArticleIdList": ["10.1016/j.jep.2011.08.063", "21920425"]}, {"Citation": "Kang S, Liu S, Li H, et al. Baicalin effects on rats with spinal cord injury by anti-inflammatory and regulating the serum metabolic disorder. J Cell Biochem. 2018;119:7767\u20137779. doi:10.1002/jcb.27136", "ArticleIdList": ["10.1002/jcb.27136", "29904952"]}, {"Citation": "Li L, Hou X, Xu R, et al. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol. 2017;31:17\u201336. doi:10.1111/fcp.12232", "ArticleIdList": ["10.1111/fcp.12232", "27567103"]}, {"Citation": "Lin J, Pan X, Huang C, et al. Dual regulation of microglia and neurons by Astragaloside IV\u2010mediated mTORC1 suppression promotes functional recovery after acute spinal cord injury. J Cell Mol Med. 2020;24:671\u2013685. doi:10.1111/jcmm.14776", "ArticleIdList": ["10.1111/jcmm.14776", "PMC6933381", "31675186"]}, {"Citation": "Zhang D, Wang Q, Wang S, et al. Astragoloside IV loaded polycaprolactone membrane repairs blood spinal cord barrier and recovers spinal cord function in traumatic spinal cord injury. J Biomed Nanotechnol. 2019;15:799\u2013812. doi:10.1166/jbn.2019.2715", "ArticleIdList": ["10.1166/jbn.2019.2715", "30841972"]}, {"Citation": "Dai W-L, Zhang L, Han L, et al. Regulation of the K ATP-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain. Reg Anesth Pain Med. 2020;45:955\u2013963. doi:10.1136/rapm-2020-101411", "ArticleIdList": ["10.1136/rapm-2020-101411", "32963077"]}, {"Citation": "Pollier J, Goossens A. Oleanolic acid. Phytochemistry. 2012;77:10\u201315. doi:10.1016/j.phytochem.2011.12.022", "ArticleIdList": ["10.1016/j.phytochem.2011.12.022", "22377690"]}, {"Citation": "Mart\u00edn R, Carvalho-Tavares J, Hern\u00e1ndez M, et al. Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role. Biochem Pharmacol. 2010;79:198\u2013208. doi:10.1016/j.bcp.2009.08.002", "ArticleIdList": ["10.1016/j.bcp.2009.08.002", "19679109"]}, {"Citation": "Wang J-L, Ren C-H, Feng J, et al. Oleanolic acid inhibits mouse spinal cord injury through suppressing inflammation and apoptosis via the blockage of p38 and JNK MAPKs. Biomed Pharmacother. 2020;123:109752. doi:10.1016/j.biopha.2019.109752", "ArticleIdList": ["10.1016/j.biopha.2019.109752", "31924596"]}, {"Citation": "Chen D, Huang C, Chen Z. A review for the pharmacological effect of lycopene in central nervous system disorders. Biomed Pharmacother. 2019;111:791\u2013801. doi:10.1016/j.biopha.2018.12.151", "ArticleIdList": ["10.1016/j.biopha.2018.12.151", "30616078"]}, {"Citation": "Zhang Q, Wang J, Gu Z, et al. Effect of lycopene on the blood-spinal cord barrier after spinal cord injury in mice. Biosci Trends. 2016;10:288\u2013293. doi:10.5582/bst.2016.01062", "ArticleIdList": ["10.5582/bst.2016.01062", "27357536"]}, {"Citation": "Hua Y, Xu N, Ma T, et al. Anti-inflammatory effect of lycopene on experimental spinal cord ischemia injury via cyclooxygenase-2 suppression. Neuroimmunomodulation. 2019;26:84\u201392. doi:10.1159/000495466", "ArticleIdList": ["10.1159/000495466", "30625493"]}, {"Citation": "Budzynska B, Faggio C, Kruk-Slomka M, et al. Rutin as neuroprotective agent: from bench to bedside. Curr Med Chem. 2019;26:5152\u20135164. doi:10.2174/0929867324666171003114154", "ArticleIdList": ["10.2174/0929867324666171003114154", "28971760"]}, {"Citation": "Zhang P, Ma X. Effect of rutin on spinal cord injury through inhibition of the expression of MIP-2 and activation of MMP-9, and downregulation of Akt phosphorylation. Mol Med Rep. 2015;12:7554\u20137560. doi:10.3892/mmr.2015.4357", "ArticleIdList": ["10.3892/mmr.2015.4357", "26502930"]}, {"Citation": "Wu J, Maoqiang L, Fan H, et al. Rutin attenuates neuroinflammation in spinal cord injury rats. J Surg Res. 2016;203:331\u2013337. doi:10.1016/j.jss.2016.02.041", "ArticleIdList": ["10.1016/j.jss.2016.02.041", "27363641"]}, {"Citation": "\u00c7ift\u00e7i U, Delen E, Vural M, et al. Efficiacy of resveratrol and quercetin after experimental spinal cord injury. Ulus Travma Acil Cerrahi Derg. 2016;22:423\u2013431. doi:10.5505/tjtes.2016.44575", "ArticleIdList": ["10.5505/tjtes.2016.44575", "27849317"]}, {"Citation": "Sch\u00fcltke E, Griebel RW, Juurlink BHJ. Quercetin attenuates inflammatory processes after spinal cord injury in an animal model. Spinal Cord. 2010;48:857\u2013861. doi:10.1038/sc.2010.45", "ArticleIdList": ["10.1038/sc.2010.45", "20440299"]}, {"Citation": "Wang Y, Li W, Wang M, et al. Quercetin reduces neural tissue damage and promotes astrocyte activation after spinal cord injury in rats. J Cell Biochem. 2018;119:2298\u20132306. doi:10.1002/jcb.26392", "ArticleIdList": ["10.1002/jcb.26392", "28865131"]}, {"Citation": "Fan H, Tang H-B, Shan L-Q, et al. Quercetin prevents necroptosis of oligodendrocytes by inhibiting macrophages/microglia polarization to M1 phenotype after spinal cord injury in rats. J Neuroinflammation. 2019;16:206. doi:10.1186/s12974-019-1613-2", "ArticleIdList": ["10.1186/s12974-019-1613-2", "PMC6839267", "31699098"]}, {"Citation": "Jiang W, Huang Y, Han N, et al. Quercetin suppresses NLRP3 inflammasome activation and attenuates histopathology in a rat model of spinal cord injury. Spinal Cord. 2016;54:592\u2013596. doi:10.1038/sc.2015.227", "ArticleIdList": ["10.1038/sc.2015.227", "26754474"]}, {"Citation": "Zhang S, Liu Y, Zhao Z, et al. Effects of green tea polyphenols on caveolin-1 of microvessel fragments in rats with cerebral ischemia. Neurol Res. 2010;32:963\u2013970. doi:10.1179/016164110X12700393823570", "ArticleIdList": ["10.1179/016164110X12700393823570", "20444327"]}, {"Citation": "Liu X, Wang Z, Wang P, et al. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling. BMC Complement Altern Med. 2013;13:187. doi:10.1186/1472-6882-13-187", "ArticleIdList": ["10.1186/1472-6882-13-187", "PMC3723424", "23870286"]}, {"Citation": "Yu D-S, Liu L-B, Cao Y, et al. Combining bone marrow stromal cells with green tea polyphenols attenuates the blood-spinal cord barrier permeability in rats with compression spinal cord injury. J Mol Neurosci. 2015;56:388\u2013396. doi:10.1007/s12031-015-0564-z", "ArticleIdList": ["10.1007/s12031-015-0564-z", "26007330"]}, {"Citation": "Lee JY, Choi HY, Baik HH, et al. Cordycepin-enriched WIB-801C from Cordyceps militaris improves functional recovery by attenuating blood-spinal cord barrier disruption after spinal cord injury. J Ethnopharmacol. 2017;203:90\u2013100. doi:10.1016/j.jep.2017.03.047", "ArticleIdList": ["10.1016/j.jep.2017.03.047", "28363523"]}, {"Citation": "Kang O-H, Lee G-H, Choi HJ, et al. Ethyl acetate extract from Angelica Dahuricae Radix inhibits lipopolysaccharide-induced production of nitric oxide, prostaglandin E2 and tumor necrosis factor-alpha via mitogen-activated protein kinases and nuclear factor-kappaB in macrophages. Pharmacol Res. 2007;55:263\u2013270. doi:10.1016/j.phrs.2006.12.001", "ArticleIdList": ["10.1016/j.phrs.2006.12.001", "17229575"]}, {"Citation": "Moon YJ, Lee JY, Oh MS, et al. Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury. J Neurosci Res. 2012;90:243\u2013256. doi:10.1002/jnr.22734", "ArticleIdList": ["10.1002/jnr.22734", "21922518"]}, {"Citation": "Tian X, Liang T, Liu Y, et al. Extraction, structural characterization, and biological functions of Lycium Barbarum Polysaccharides: a review. Biomolecules. 2019;9:389. doi:10.3390/biom9090389", "ArticleIdList": ["10.3390/biom9090389", "PMC6770593", "31438522"]}, {"Citation": "Zhang Y-K, Wang J, Liu L, et al. The effect of Lycium barbarum on spinal cord injury, particularly its relationship with M1 and M2 macrophage in rats. BMC Complement Altern Med. 2013;13:67. doi:10.1186/1472-6882-13-67", "ArticleIdList": ["10.1186/1472-6882-13-67", "PMC3618261", "23517687"]}, {"Citation": "Gillessen A, Schmidt HH-J. Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther. 2020;37:1279\u20131301. doi:10.1007/s12325-020-01251-y", "ArticleIdList": ["10.1007/s12325-020-01251-y", "PMC7140758", "32065376"]}, {"Citation": "Tsai M-J, Liao J-F, Lin D-Y, et al. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation. Neurochem Int. 2010;57:867\u2013875. doi:10.1016/j.neuint.2010.09.005", "ArticleIdList": ["10.1016/j.neuint.2010.09.005", "20868716"]}, {"Citation": "Yune TY, Lee JY, Cui CM, et al. Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats. J Neurochem. 2009;110:1276\u20131287. doi:10.1111/j.1471-4159.2009.06214.x", "ArticleIdList": ["10.1111/j.1471-4159.2009.06214.x", "19519665"]}, {"Citation": "Tu T-H, Liou D-Y, Lin D-Y, et al. Characterizing the neuroprotective effects of S/B remedy (Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd) in spinal cord injury. Molecules. 2019;24:1885. doi:10.3390/molecules24101885", "ArticleIdList": ["10.3390/molecules24101885", "PMC6571778", "31100896"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "20"}, {"Year": "2021", "Month": "10", "Day": "12"}, {"Year": "2021", "Month": "11", "Day": "12", "Hour": "6", "Minute": "58"}, {"Year": "2021", "Month": "11", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "13", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "11", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["34764668", "PMC8576359", "10.2147/JIR.S329864", "329864"]}}], "PubmedBookArticle": []}